dr. becerra discusses regorafenib dosing in metastatic crc
Published 6 years ago • 37 plays • Length 2:08Download video MP4
Download video MP3
Similar videos
-
1:01
dr. becerra discusses an investigational cellular therapy in crc
-
5:53
redos trial: optimizing regorafenib dosing in metastatic colorectal cancer
-
0:42
dr. bendell on the future of regorafenib for patients with crc
-
8:47
colorectal cancer: dosing strategies with regorafenib
-
3:53
regorafenib in colorectal cancer: optimizing the dose
-
1:04
dr. randall holcombe discusses regorafenib for metastatic colorectal cancer
-
1:36
optimal dosing of regorafenib in colorectal cancer
-
10:02
role of the multikinase inhibitor regorafenib in metastatic colorectal cancer
-
1:16
dr. o'connor discusses regorafenib dosing in mcrc
-
9:34
regorafenib in colorectal cancer
-
6:33
patient selection for regorafenib in crc
-
1:05
dr. corcoran on the utility of regorafenib in crc
-
1:39
dr. bekaii-saab on dosing strategies with regorafenib in crc
-
8:14
optimizing treatment with regorafenib in metastic colorectal cancer
-
1:30
dr. nancy l. lewis discusses the correct trial for regorafenib in metastatic colorectal cancer
-
1:16
dr. eng on roles of regorafenib and tas-102 in crc treatment
-
8:26
regorafenib in advanced colorectal cancer: dosing strategies
-
5:32
colorectal cancer: regorafenib patient selection and dosing
-
5:31
practical advice for using regorafenib